FHIR © HL7.org | Server Home | FHIR Server FHIR Server 3.7.13 | FHIR Version n/a User: [n/a]

724144006: Embryofetopathy caused by methimazole (disorder)

SNOMED CT Concept\Clinical finding\Disease\...

\Congenital disease\Congenital anomaly\Congenital malformation syndrome\Methimazole embryofetopathy

\Developmental disorder\Congenital anomaly\Congenital malformation syndrome\Methimazole embryofetopathy

Status: current, Primitive. Date: 31-Jul 2017. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3431096018 Embryofetopathy caused by methimazole (disorder) en Fully specified name Active Case insensitive SNOMED CT core

3431097010 Methimazole embryofetopathy en Synonym Active Case insensitive SNOMED CT core

3431098017 Embryofetopathy caused by methimazole en Synonym Active Case insensitive SNOMED CT core

3431099013 A teratogenic embryofetopathy that results from maternal exposition to methimazole in the first trimester of pregnancy. Methimazole is an antithyroid thionamide drug used for the treatment of Graves' disease. In the infant, methimazole may result in choanal atresia, esophageal atresia, omphalocele, omphalomesenteric duct anomalies, congenital heart disease (such as ventricular septal defect), renal system malformations and aplasia cutis. Additional features that may be observed include facial dysmorphism (short up slanting palpebral fissures, a broad nasal bridge with a small nose and a broad forehead) and athelia. en Definition Active Case sensitive SNOMED CT core

3431100017 A teratogenic embryofetopathy that results from maternal exposition to methimazole in the first trimester of pregnancy. Methimazole is an antithyroid thionamide drug used for the treatment of Graves' disease. In the infant, methimazole may result in choanal atresia, oesophageal atresia, omphalocele, omphalomesenteric duct anomalies, congenital heart disease (such as ventricular septal defect), renal system malformations and aplasia cutis. Additional features that may be observed include facial dysmorphism (short up slanting palpebral fissures, a broad nasal bridge with a small nose and a broad forehead) and athelia. en Definition Active Case sensitive SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Methimazole embryofetopathy	Pathological process	Pathological developmental process	true	Inferred relationship	Some	1
Methimazole embryofetopathy	Associated morphology	Morphologically abnormal structure	true	Inferred relationship	Some	1
Methimazole embryofetopathy	Is a	Congenital malformation syndrome	true	Inferred relationship	Some
Methimazole embryofetopathy	Is a	Disorder by body site	false	Inferred relationship	Some
Methimazole embryofetopathy	Is a	Drug-related disorder	false	Inferred relationship	Some
Methimazole embryofetopathy	Is a	Congenital malformation syndrome due to known exogenous cause	false	Inferred relationship	Some
Methimazole embryofetopathy	Is a	Disorder of fetal structure	false	Inferred relationship	Some
Methimazole embryofetopathy	Associated morphology	Developmental abnormality	false	Inferred relationship	Some	1
Methimazole embryofetopathy	Causative agent	Thiamazole	true	Inferred relationship	Some	1
Methimazole embryofetopathy	Occurrence	Congenital	true	Inferred relationship	Some	1
Methimazole embryofetopathy	Finding site	Fetal structure	true	Inferred relationship	Some	1

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

Reference Sets

Australian emergency department reference set

Clinical finding foundation reference set

Problem/Diagnosis reference set

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3431096018	Embryofetopathy caused by methimazole (disorder)	en	Fully specified name	Active	Case insensitive	SNOMED CT core
3431097010	Methimazole embryofetopathy	en	Synonym	Active	Case insensitive	SNOMED CT core
3431098017	Embryofetopathy caused by methimazole	en	Synonym	Active	Case insensitive	SNOMED CT core
3431099013	A teratogenic embryofetopathy that results from maternal exposition to methimazole in the first trimester of pregnancy. Methimazole is an antithyroid thionamide drug used for the treatment of Graves' disease. In the infant, methimazole may result in choanal atresia, esophageal atresia, omphalocele, omphalomesenteric duct anomalies, congenital heart disease (such as ventricular septal defect), renal system malformations and aplasia cutis. Additional features that may be observed include facial dysmorphism (short up slanting palpebral fissures, a broad nasal bridge with a small nose and a broad forehead) and athelia.	en	Definition	Active	Case sensitive	SNOMED CT core
3431100017	A teratogenic embryofetopathy that results from maternal exposition to methimazole in the first trimester of pregnancy. Methimazole is an antithyroid thionamide drug used for the treatment of Graves' disease. In the infant, methimazole may result in choanal atresia, oesophageal atresia, omphalocele, omphalomesenteric duct anomalies, congenital heart disease (such as ventricular septal defect), renal system malformations and aplasia cutis. Additional features that may be observed include facial dysmorphism (short up slanting palpebral fissures, a broad nasal bridge with a small nose and a broad forehead) and athelia.	en	Definition	Active	Case sensitive	SNOMED CT core